<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Transl Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Am J Transl Res</journal-id>
<journal-id journal-id-type="publisher-id">ajtr</journal-id>
<journal-title-group>
<journal-title>American Journal of Translational Research</journal-title>
</journal-title-group>
<issn pub-type="epub">1943-8141</issn>
<publisher>
<publisher-name>e-Century Publishing Corporation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28078038</article-id>
<article-id pub-id-type="pmc">5209518</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Insulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Moreno-Indias</surname>
<given-names>Isabel</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
<xref ref-type="aff" rid="au2">2</xref>
<xref ref-type="author-notes" rid="fn1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sánchez-Alcoholado</surname>
<given-names>Lidia</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
<xref ref-type="author-notes" rid="fn1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>García-Fuentes</surname>
<given-names>Eduardo</given-names>
</name>
<xref ref-type="aff" rid="au2">2</xref>
<xref ref-type="aff" rid="au3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cardona</surname>
<given-names>Fernando</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
<xref ref-type="aff" rid="au2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Queipo-Ortuño</surname>
<given-names>Maria Isabel</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
<xref ref-type="aff" rid="au2">2</xref>
<xref ref-type="author-notes" rid="fn1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tinahones</surname>
<given-names>Francisco J</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
<xref ref-type="aff" rid="au2">2</xref>
</contrib>
<aff id="au1">
<label>1</label>
<institution>Clinical Management Unit of Endocrinology and Nutrition, Laboratory of The Biomedical Research Institute of Malaga (IBIMA), Virgen de la Victoria University Hospital, Malaga University</institution>
<addr-line>Malaga, Spain</addr-line>
</aff>
<aff id="au2">
<label>2</label>
<institution>Biomedical Research Networking Center for Pathophysiology of Obesity and Nutrition</institution>
<addr-line>Madrid, Spain</addr-line>
</aff>
<aff id="au3">
<label>3</label>
<institution>Clinical Management Unit of Endocrinology and Nutrition, Biomedical Research Institute of Malaga (IBIMA), Regional University Hospital</institution>
<addr-line>Malaga, Spain</addr-line>
</aff>
</contrib-group>
<author-notes>
<corresp><bold>Address correspondence to:</bold> Maria Isabel Queipo-Ortuño, Laboratorio de Investigación Biomédica 1ª planta, Instituto de Investigación Biomédica (IBIMA), Complejo Hospitalario de Málaga (Virgen de la Victoria), Campus de Teatinos s/n 29010-Malaga, Spain. Tel: 34/951032647; E-mail: <email>maribelqo@gmail.com</email></corresp>
<fn id="fn1">
<label>*</label>
<p>Equal contributors.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>8</volume>
<issue>12</issue>
<fpage>5672</fpage>
<lpage>5684</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>6</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>AJTR Copyright © 2016</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Alterations in intestinal microbiota composition could promote a proinflammatory state in adipose tissue that is associated with obesity and insulin resistance. Our aim was to identify the gut microbiota associated with insulin resistance in appendix samples from morbidly obese patients classified in 2 groups, high (IR-MO) and low insulin-resistant (NIR-MO), and to determine the possible association between these gut microbiota and variables associated with insulin resistance and the expression of genes related to inflammation and macrophage infiltration in adipose tissue. Appendix samples were obtained during gastric bypass surgery and the microbiome composition was determined by 16S rRNA pyrosequencing and bioinformatics analysis by QIIME. The Chao and Shannon indices for each study group suggested similar bacterial richness and diversity in the appendix samples between both study groups. 16S rRNA pyrosequencing showed that the IR-MO group had a significant increase in the abundance of <italic>Firmicutes</italic>, <italic>Fusobacteria</italic>, <italic>Pseudomonaceae</italic>, <italic>Prevotellaceae</italic>, <italic>Fusobacteriaceae</italic>, <italic>Pseudomonas</italic>, <italic>Catenibacterium</italic>, <italic>Prevotella</italic>, <italic>Veillonella</italic> and <italic>Fusobacterium</italic> compared to the NIR-MO group. Moreover, in the IR-MO group we found a significant positive correlation between the abundance of <italic>Prevotella</italic>, <italic>Succinovibrio</italic>, <italic>Firmicutes</italic> and <italic>Veillonella</italic> and the visceral adipose tissue expression level of IL6, TNF alpha, ILB1 and CD11b respectively, and significant negative correlations between the abundance of <italic>Butyricimonas</italic> and <italic>Bifidobacterium</italic>, and plasma glucose and insulin levels, respectively. In conclusion, an appendix dysbiosis occurs in IR-MO patients, with a loss of butyrate-producing bacteria, essential to maintenance of gut integrity, together with an increase in mucin-degrading bacteria and opportunistic pathogens. The microbiota present in the IR-MO group were related to low grade inflammation in adipose tissue and could be useful for developing strategies to control the development of insulin resistance.</p>
</abstract>
<kwd-group>
<kwd>Microbiota</kwd>
<kwd>appendix</kwd>
<kwd>insulin resistance</kwd>
<kwd>gut integrity</kwd>
<kwd>inflammation</kwd>
<kwd>adipose tissue</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>